Recurrence Clinical Trial
Official title:
A Retrospective/Prospective, Post-market, Multi-center Evaluation of the Clinical Outcomes of the Triathlon Hinge Knee (THK) System
This study is a prospectively and retrospectively enrolled, post-market, open-label, non-randomized, single institution evaluation of clinical outcomes of primary or revision knee surgery patients who meet the eligibility criteria and received devices from the Triathlon Hinge Knee System according to its indications for use (IFU). Clinical evaluation for all cases will include data collection of patient demographics, surgical details, early postoperative status, functional and clinical outcomes, and survivorship at 1, 2, 6, and 10-years.
The purpose of this study is to evaluate the safety and performance of the Triathlon Hinge Knee System for both primary and revision cases in accordance with the Indications for Use. The main objective of this study is to determine (1) mid- (5 year) and long-term (10 year) survivorship, and (2) drivers of failure for the THK hinge. Data from this study will be used to develop a predictive model to identify the most important factors in achieving fixation, including the role of augments, cones, thresholds for cement mantle thickness, and number of zones of fixation required for survivorship. Survivorship is defined as the absence of aseptic revision to the implanted device. The Triathlon Hinge Knee System consists of Triathlon Hinge femoral components, the Triathlon Revision baseplate, Triathlon Revision Tibial Augments, Triathlon Hinge Femoral Distal Augments, Triathlon Hinge Insert, Triathlon Revision Insert X3, and Triathlon Hinge Bumpers, Axle, Bushings, Tibial Sleeve, and Bearing component. It is designed to be a single platform for revision, difficult primary, and limb salvage surgeries. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03545659 -
Childhood Acute Lymphoblastic Leukaemia: Follow-Up
|
||
| Completed |
NCT04838613 -
Study of Diagnostic Performance of [18F]CTT1057 in BCR
|
Phase 3 | |
| Recruiting |
NCT05233020 -
Robotic Versus Hybrid Assisted Ventral Hernia Repair
|
N/A | |
| Recruiting |
NCT04539665 -
Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease.
|
N/A | |
| Recruiting |
NCT04266600 -
Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease
|
N/A | |
| Terminated |
NCT03257722 -
Pembrolizumab + Idelalisib for Lung Cancer Study
|
Phase 1/Phase 2 | |
| Completed |
NCT01141335 -
Polypropylene Mesh Versus Polytetrafluoroethylene (PTFE) Mesh in Inguinal Hernia Repair
|
Phase 4 | |
| Completed |
NCT00029185 -
Study of Dehydrex in Patients With Corneal Erosion
|
N/A | |
| Completed |
NCT01351974 -
Sentinel Node Biopsy in Breast Cancer Patients
|
N/A | |
| Not yet recruiting |
NCT06038422 -
GTP Regimen in the Treatment of Refractory/Recurrent HLH
|
Phase 3 | |
| Withdrawn |
NCT03162120 -
Comparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial Fibrillation
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04159051 -
Charité HT-Prostate
|
N/A | |
| Recruiting |
NCT02566928 -
Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence
|
Phase 4 | |
| Completed |
NCT01989845 -
Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer
|
Phase 4 | |
| Recruiting |
NCT01229475 -
Stepwise Approach Versus Linear Ablation in Patients With Recurrence of Persistent Atrial Fibrillation
|
N/A | |
| Completed |
NCT00944554 -
Relapse Prevention With Varenicline
|
Phase 4 | |
| Terminated |
NCT02247258 -
Azathioprine in the Prevention of Ileal Crohn's Disease Postoperative Recurrence.
|
Phase 2 | |
| Completed |
NCT03654209 -
Post-resection Treatment of Large Colon Polyps
|
N/A | |
| Recruiting |
NCT05557474 -
Development and Clinical Validation of Early-stage Lung Cancer Prognostic Kit
|
||
| Active, not recruiting |
NCT03865537 -
Cold Snare Endoscopic Mucosal Resection Trial
|
N/A |